Oceanyx Pharmaceuticals is a novel drug discovery and development company leveraging marine cyanobacteria-based natural product research...
Read More...

Oceanyx technology platform evaluates chemical properties of marine cyanobacterial genome through a “high content” functional genomics screening...
Read More...

Oceanyx Pharmaceuticals continues to build a platform of novel drugs from its marine biology (cyanobacteria)-based natural product chemistry...
Read More...

Oceanyx has identified several novel and diverse chemical series from the marine cyanobacteria-based drug discovery initiatives for treating various...
Read More...

Oceanyx’s first two lead candidates, largazole and apratoxin S4, that selectively target Class I HDACs and specific targets in the cotranslational...
Read More...

Dr. Chaturvedi is the Chief Executive Officer of IndUS Pharmaceuticals and the Chief Scientific Officer of Napo Pharmaceuticals.  Prior to IndUS and Napo...
Read More...